Innovative technologies like array comparative genomic hybridization (arrayCGH), single nucleotide polymorphism (SNP) arrays and next-generation sequencing revealed recurrent mutations of genes implicated in epigenetic control such as ASXL1, EZH2, DNMT3A and TET2 in MDS and AML. This evidence concerns the gene EZH2 and myelodysplastic syndrome.